Santander Plans to Cut 100 Jobs at Its Italian Consumer Bank
Banco Santander SA is planning to cut about 100 roles at its Italian consumer finance unit as part of a wider strategy to do away with branches in the country.
Bloomberg Business
Trump Rebuffed From Discussing Mar-a-Lago Evidence at Mar-a-Lago
A federal judge refused to give former President Donald Trump permission to discuss classified documents at the place where he allegedly mishandled them — his Mar-a-Lago resort.
JPMorgan Elevates Hofmann, Carpenter to Run North America M&A
JPMorgan Chase & Co. named Jay Hofmann and Ben Carpenter co-heads of mergers and acquisitions advisory in North America, according to a memo reviewed by Bloomberg News.
Subprime-Focused Car Dealer U.S. Auto Sales Goes Bankrupt
U.S. Auto Sales Inc., a car dealer that catered to consumers regardless of their credit history, quietly filed for bankruptcy late last month as more Americans fall behind on their car payments.
Charter CFO Says Disney Deal Will ‘Stabilize’ Cable-TV Business
Charter Communications Inc. Chief Financial Officer Jessica Fischer described the recent contract renewal with Walt Disney Co. as a victory for pay-TV providers.
D1’s Big Bets on Venture Capital Are Weighing Down Its Returns
D1 Capital Partners’s massive exposure to private bets is weighing on returns, making it one of the year’s worst-performing crossover funds.
Caesars Palace Exits Dubai Just as the UAE Moves Toward Legalized Gaming
The property will be rebranded as a Banyan Tree resort as of November.
US Consumer Prices Jump, Straining Household Budgets Even More
US inflation rose in August by the most in over a year as a pickup in prices at the gas pump exacerbated already strained household budgets.
China Sows Fresh Confusion About Apple With Security Remarks
The Chinese government’s position on Apple Inc. only grew more muddled Wednesday, with Beijing both pushing back on reports about iPhone restrictions but also raising concerns about security problems with the device.
Moderna Poised to Seek Flu Shot Approval After Trial Results
Moderna Inc. said a reformulated version of its messenger-RNA based flu shot met its primary goals in a final-stage trial — a result that could pave the way for the company to seek regulatory approval for the influenza vaccine.
